Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture

Area of Science:

• Neuroscience
• Psychiatry
• Nutritional Science

Background:

• Inflammation plays a key role in the pathophysiology of bipolar disorder.
• Omega-3 (n-3) and omega-6 (n-6) polyunsaturated fatty acid (PUFA) pathways are involved in inflammatory processes.
• PUFA metabolism has been linked to bipolar disorder and treatment response.

Purpose of the Study:

• To review the role of PUFA metabolism in neuroinflammation.
• To examine the impact of antimanic medications on brain PUFA metabolism in rodent models.
• To assess anti-inflammatory pharmacotherapy in bipolar disorder and major depressive disorder (MDD).

Main Methods:

• Review of preclinical and clinical studies on PUFA metabolism in bipolar disorder.
• Analysis of rodent models investigating medication effects on brain PUFA metabolism.
• Examination of human trials evaluating PUFA treatment for bipolar disorder and MDD.

Main Results:

• Preclinical and postmortem data suggest a compelling link between PUFA metabolism and bipolar disorder.
• Human trials of PUFA treatment for bipolar disorder have yielded mixed results.
• Evidence supports the hypothesis that arachidonic acid hypermetabolism contributes to bipolar disorder pathophysiology.

Conclusions:

• A combined high n-3 plus low n-6 dietary intervention warrants testing as an adjunct to current bipolar disorder medications.
• Further research is needed to clarify the discrepancies in human trials of PUFA treatment.
• Understanding PUFA metabolism offers potential therapeutic avenues for bipolar disorder and MDD.